Abstract

BackgroundPopulation-based and longitudinal information regarding sexual risk behavior among patients with multidrug resistant (MDR) HIV and their sexual partners is of great public health and clinical importance.ObjectiveTo characterize the HIV sexual risk behaviors of patients with and without drug-resistant HIV in the clinical care setting over time.Measurements393 HIV-positive patients completed questionnaires of self-reported sexual risk behaviors at approximate 6-month intervals extending over 24 months. HIV viral load and genotypic drug resistance obtained during the same time points were matched to the behavioral data. Multidrug resistance was defined as having resistance to 2 or 3 antiretroviral (ARV) drug classes.ResultsIn serial cross-sectional analyses, 393 patients (44% female and 79% heterosexual) contributed 919 matched behavioral and virologic results over the 24 months of data collection. Of these, 250 patients (64%) reported having sex during at least 1 survey period resulting in greater than 10,000 sexual events with more than 1000 partners. Unprotected sexual behavior was reported by 45% of sexually active patients, resulting in 34% of all sex events that exposed 29% of all partners. Of these patients with unprotected sexual events, 31% had HIV drug resistance 11.6% with resistance to 2 classes of ARVs (2-class), and 1.8% with 3-class ARV resistance at the time of a sexual risk event. Close to 1000 or 28% of all unprotected sexual events involved resistant strains (11% of these with resistance to 2 classes and 0.2% with 3-class resistance, exposing 20% of unprotected sexual partners to resistant HIV (8% to 2-class and 0.6% to 3-class resistance).In longitudinal analysis among the 78 patients who reported a cumulative total of 12 months of sexual history and had resistance testing, 38% reported engaging in unprotected sexual behavior. There was substantial and complex variation in the distribution of unprotected sexual events and in the detection of resistance over time.ConclusionIn this study of HIV sexual risk and resistance over time among HIV-infected patients in clinical care, a substantial proportion engaged in unprotected sex and had drug-resistant HIV, frequently exposing partners to 1- or 2-class resistant HIV strains. However, relatively few exposures involved 3-class resistance. The dynamics of sexual risk behavior and HIV drug resistance are complex and vary over time and urgently require both general and targeted interventions to reduce transmission of resistant HIV.

Highlights

  • The transmission of drug-resistant strains of HIV-1 to newly infected persons is a major clinical and public health problem in developed countries with availability of antiretroviral (ARV) therapy during the past decades

  • In longitudinal analysis among the 78 patients who reported a cumulative total of 12 months of sexual history and had resistance testing, 38% reported engaging in unprotected sexual behavior

  • Transmitted multidrug resistant (MDR) HIV-1 strains that possess viral mutations that result in 2- or 3-class drug resistance can profoundly affect the response to ARV therapy.[1,2,8]

Read more

Summary

Introduction

The transmission of drug-resistant strains of HIV-1 to newly infected persons is a major clinical and public health problem in developed countries with availability of antiretroviral (ARV) therapy during the past decades. Important anecdotal and cross-sectional information on sexual risk behavior of patients with drug-resistant HIV is available,[8,11,12] studies have generally not provided population-based information over time on the quantitative aspects and dynamics of the relationship of sexual risk and resistance. The data needed to more fully understand this relationship include: (1) cumulative proportion of patients with MDR HIV strains who engage in unprotected sexual behavior, (2) the number of sexual events involving such individuals, and (3) the number of partners thereby exposed to resistant strains. Population-based and longitudinal information regarding sexual risk behavior among patients with multidrug resistant (MDR) HIV and their sexual partners is of great public health and clinical importance

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call